Screener
Eligibility screening
the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
7 US sites in NJ, NY
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.